Table 4.
Primary versus recurrent GBM sample continuous variables.
Variable | Group | n | Mean (yrs or % positive staining) |
SD | p value |
---|---|---|---|---|---|
Age | Primary | 38 | 61.05 | 10.67 | 0.0009 |
Recurrent | 11 | 43.36 | 12.71 | ||
CD3 | Primary | 37 | 0.35 | 0.44 | 0.9416 |
Recurrent | 11 | 0.33 | 0.35 | ||
CD8 | Primary | 36 | 0.12 | 0.14 | 0.1937 |
Recurrent | 11 | 0.30 | 0.44 | ||
CD68 | Primary | 38 | 5.20 | 3.39 | 0.7120 |
Recurrent | 11 | 5.46 | 2.06 | ||
CD163 | Primary | 38 | 6.12 | 6.40 | 0.7658 |
Recurrent | 11 | 5.56 | 3.72 | ||
FOXP3 | Primary | 37 | 0.35 | 0.47 | 0.9279 |
Recurrent | 10 | 0.37 | 0.47 | ||
PDL1 | Primary | 37 | 8.11 | 7.66 | 0.4508 |
Recurrent | 11 | 7.42 | 4.34 | ||
CTLA4 | Primary | 38 | 0.43 | 0.59 | 0.9525 |
Recurrent | 11 | 0.27 | 0.23 | ||
CD70 | Primary | 34 | 0.69 | 1.38 | 0.3401 |
Recurrent | 6 | 0.82 | 0.79 | ||
PD1 | Primary | 38 | 1.42 × 105 | 3.95 × 105 | 0.4888 |
Recurrent | 11 | 0.38 × 105 | 0.75 × 105 |
The patient age and percent positive cell expression of immune markers are shown in primary and recurrent samples. The primary samples were associated with older patients compared to recurrent samples. No significant differences in immune marker expression was found between primary and recurrent samples.